NCT06049134 2026-03-09Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 TherapyM.D. Anderson Cancer CenterPhase 4 Active not recruiting30 enrolled